Initial results of two phase I trials delivering mbIL-21 ex vivo expanded haploidentical NK cells after fludarabine/cytarabine for patients with relapsed/refractory myeloid leukemias.

7008Background: NK cells play an important role in the control of malignancies but are ablated by high-dose chemotherapy. Thus, rapid recovery of NK cell number and function correlates with improve...